企業プロフィール
Unicycive Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- UNCY
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
5.57 USD (+1.09%)
終値
最終更新: 2026年8月17日
193M USD
時価総額
株価変動の要因
As of Aug 17, 2026, UNCY closed up 1.09% at $5.57. No new same-company headline was identified in the current news window.
企業概要
Kidney Disease Therapeutics
Unicycive Therapeutics develops medicines for conditions associated with chronic kidney disease.
Oxylanthanum Carbonate
Oxylanthanum carbonate is an oral phosphate binder for hyperphosphatemia in dialysis patients. It is designed to achieve phosphate control with a lower pill burden than commonly used therapies.
Regulatory Resubmission Path
The FDA's prior review did not identify efficacy or safety deficiencies but required resolution of manufacturing-facility issues. A third-party vendor inspection is the key step preceding NDA resubmission.
今後のカタリスト
- Completion of the FDA inspection of the third-party oxylanthanum carbonate manufacturing facility.
- Resubmission of the oxylanthanum carbonate NDA following a successful facility inspection.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。